Clinical Scorecard: Visual Rehabilitation With a Scleral Lens in an Eye With Corneal Scarring
At a Glance
| Category | Detail |
|---|---|
| Condition | Corneal Scarring |
| Key Mechanisms | Scleral lenses provide optical benefits and sustained ocular drug delivery. |
| Target Population | Patients with corneal scarring from disease, trauma, or surgical complications. |
| Care Setting | Ophthalmology clinic |
Key Highlights
- Successful visual rehabilitation using a BostonSight Scleral lens.
- Topical losartan administered to reduce corneal scar density.
- Best-corrected visual acuity improved from hand motion to 20/20.
- Scleral lens design included SmartChannels for enhanced tear exchange.
- Topical losartan is off-label for reducing corneal scarring.
Guideline-Based Recommendations
Diagnosis
- Assess visual acuity and slit lamp findings for corneal scarring.
Management
- Fit scleral lenses for visual rehabilitation and sustained drug delivery.
Monitoring & Follow-up
- Monitor visual acuity and ocular surface condition during treatment.
Risks
- Topical losartan is not FDA approved for corneal scarring; potential for epithelial toxicity.
Patient & Prescribing Data
25-year-old female with keratoconus and corneal scarring.
Topical losartan 0.8 mg/ml administered 4 times daily in the scleral lens.
Clinical Best Practices
- Incorporate SmartChannels in scleral lenses for patients with neovascularization.
- Continue monitoring for optimal visual acuity and subjective visual quality.
Related Resources & Content
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.